|

A Study to Compare Two Rehabilitation Protocols for Knee Osteoarthritis

RECRUITINGN/ASponsored by Ente Ospedaliero Cantonale, Bellinzona
Actively Recruiting
PhaseN/A
SponsorEnte Ospedaliero Cantonale, Bellinzona
Started2023-03-15
Est. completion2025-09
Eligibility
Age45 Years – 80 Years
Healthy vol.Accepted

Summary

The aim of this randomized controlled study is to investigate whether the implementation of Blood Flow Restriction, in which the de-loading factor is delivered by the combined progressive de-loaded walking to running activity on an antigravity treadmill (treatment group), is more effective than the same antigravity protocol alone (control group). Participants will be divided as follows: Intervention group: anti-gravity treadmill combined with blood flow restriction Control group: anti-gravity treadmill Both groups will also undergo a standardized knee Osteoarthritis management through an aerobic and strength program.

Eligibility

Age: 45 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age included between 45 and 80 years old
* Patients with knee OA diagnosed by a medical doctor with a radiological confirmation
* Patients able to provide informed consent and follow all the study procedures as indicated by the protocol
* Informed Consent as documented by signature

Exclusion Criteria:

* Younger than 44 years old or older than 81 years old included
* Known drug or alcohol abuse
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
* Participation in another study with an investigational drug within the 30 days preceding and during the present study
* Treatment with an injective approach in the previous 3 month
* Surgical treatment in the previous 12 months.

Conditions2

ArthritisKnee Osteoarthritis

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.